Method for the qualitative and quantitative determination of hydrogen peroxide
EP1454632A1
Pharmaceutical preparation for the treatment of blood-clotting disorders containing factor VIII derived peptides
DE10355408A1
Use of a C1-esterase inhibitor comprising a sialic-acid-containing glycoprotein that neutralizes viruses and their toxic components pathogenic to human, for diagnosing, treating and preventing acute viral infections
EP1411358A1
Method for the determination of plasma protein multimers
EP1400248A1
Process for sterilization of protein containing biological compositions
EP1350520A1
Human transferrin for treatment of anaemia of chronic disease (ACD) and functional iron deficiency
US7153679B2
Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis
EP1444986A1
Pharmaceutical preparation for the improved treatment of blood-clotting disorders
EP1344532A1
High molecular weight kininogen (HK) domain 5 derived peptides against thrombic diseases
DE10301884A1
Sterile case for a hypodermic syringe
DE10261126A1
Storage-stable, liquid fibrinogen formulation
EP1426382A1
Antiviral human serum albumin
EP1424344A1
Modified cDNA factor VIII and its derivates
EP1317930A1
Antithrombin for prevention and therapy of vascular proliferative diseases
EP1324041A1
Test system to analyze a biological fluid
DE10246125A1
Concentrate of a factor VIII: von Willebrand factor containing C and the associated method
EP1415669A1
Process for sterilization of protein containing biological compositions
EP1283263A1
Modified cDNA for high expression levels of factor VIII and its derivatives
DE10212008A1
needle holder
DE10211632A1
Process for the separation of viruses from a protein solution by nanofiltration
